Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum WELL Health Technologies Corp WHTCF


Primary Symbol: T.WELL Alternate Symbol(s):  T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and... see more

TSX:WELL - Post Discussion

WELL Health Technologies Corp > Revised Targets
View:
Post by retiredcf on Nov 15, 2023 8:47am

Revised Targets

Desjardins’ Jerome Dubreuil cut his WELL Health Technologies Corp.  target to $5.25 from $5.50 with a “hold” recommendation, while Stifel’s Justin Keywood trimmed his Street-high target to $11 from $12 with a “buy” rating. The average is $7.96.

“WELL reported results which were slightly ahead of expectations,” said Mr. Dubreuil. “The company also provided 2024 revenue guidance which slightly beat consensus. However, profitability growth is lagging top-line improvement and management appears to be tilting capital allocation toward primary care. Although attractive consolidation opportunities exist in this segment, we believe these operations are not as scalable as pure technology, and therefore we do not think the 13 times EV/2024 EBITDA is particularly attractive.”

Comment by prophetoffactz on Nov 15, 2023 3:49pm
Is this the problem? "...management appears to be tilting capital allocation toward primary care. Although attractive consolidation opportunities exist in this segment, we believe these operations are not as scalable as pure technology, and therefore we do not think the 13 times EV/2024 EBITDA is particularly attractive.”"  
Comment by retiredcf on Nov 15, 2023 4:06pm
Remember that this is the opinion of the most negative of the analysts who also has the lowest target. And the stop losses is a very valid point and they may be kicking themselves tomorrow. For if they suddenly have a capital loss that they would like to use, they won't be able to jump back in for 30 days. GLTA
Comment by Nextmillionaire on Nov 15, 2023 5:41pm
Leadership rocks at WELL - love them all especially Mr Sabatino. Soon we will have a major green bounce
Comment by retiredcf on Nov 16, 2023 7:09am
  Based on your posting history, is it safe to assume that you sold your BNS in order to buy WELL? If so, good move (especially if you purchased it yesterday). GLTA 
Comment by ahsh1kah on Nov 16, 2023 10:25am
Right.  And according to tipranks, this gentelment one year success rate is 29%,  average return is negative 7%.   Only 6 out of 21 ratings made a profit. .   He has one star and a rank of #6867 out of #8631 Wall Street Analysts !!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities